HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Sideroblastic anemia — Clinical Guidelines

Overview

Sideroblastic anemia is a heterogeneous group of disorders characterized by impaired heme synthesis, leading to anemia and the presence of ringed sideroblasts in bone marrow. It can be inherited, often X-linked due to ALAS2 mutations, or acquired, sometimes associated with medications or other conditions. 3 7

Diagnosis

Clinical Presentation: Anemia with microcytic or normocytic red blood cells, often associated with ineffective erythropoiesis.

Bone Marrow Examination: Presence of ringed sideroblasts, indicating iron accumulation in mitochondria of erythroid precursors.

Genetic Testing: Mutation analysis of ALAS2 for X-linked sideroblastic anemia; consider other genes for inherited forms.

Differential Diagnosis: Rule out iron deficiency, thalassemia, and other causes of anemia with appropriate biochemical tests.

Serum Biochemistry: Evaluate for associated deficiencies or toxicities (e.g., copper, zinc).

Imaging and Other Tests: Cardiac involvement may require echocardiography; other organ function tests based on clinical suspicion. 3 7 10

Management

Pyridoxine Supplementation: Beneficial in some X-linked cases; dose varies but often starts at 50-100 mg daily. 3

Chelation Therapy: Used in cases with significant iron overload, especially in pregnancy or organ dysfunction.

Drug Cessation: Discontinue offending agents like lincomycin if acquired sideroblastic anemia is drug-induced.

Blood Transfusions: For severe anemia unresponsive to other treatments, particularly in pediatric patients.

Supportive Care: Manage symptoms and complications, including cardiac monitoring in cases with mitochondrial involvement.

Specific Treatments: Danazol ineffective in acquired idiopathic cases; riboflavin may help in riboflavin-responsive forms. 3 20 24

Special Populations

Pregnancy: Monitor closely for exacerbation of anemia; chelation therapy and transfusions may be necessary. 3

Pediatrics: Early diagnosis crucial; regular transfusions and chelation may prevent organ damage. 17

Comorbidities: Consider mitochondrial myopathy overlap; manage lactic acidosis and exercise intolerance carefully. 6 18

Key Recommendations

Perform bone marrow biopsy to identify ringed sideroblasts for definitive diagnosis (Evidence: Strong 3).

Initiate pyridoxine supplementation in suspected X-linked sideroblastic anemia, monitoring response (Evidence: Moderate 3).

Discontinue or avoid medications known to cause sideroblastic anemia (e.g., lincomycin) (Evidence: Moderate 24).

Employ chelation therapy in cases with significant iron overload or organ dysfunction (Evidence: Expert opinion).

Regular blood transfusions may be required in severe, transfusion-dependent cases, especially in pediatric patients (Evidence: Moderate 17).

Monitor and manage cardiac involvement in patients with suspected mitochondrial myopathy (Evidence: Moderate 6 18).

References

1 Finsterer J, Zarrouk-Mahjoub S. Kearns-Sayre syndrome is genetically and phenotypically heterogeneous. La Pediatria medica e chirurgica : Medical and surgical pediatrics 2018. link 2 Darin N, Hedberg-Oldfors C, Kroksmark AK, Moslemi AR, Kollberg G, Oldfors A. Benign mitochondrial myopathy with exercise intolerance in a large multigeneration family due to a homoplasmic m.3250T>C mutation in MTTL1. European journal of neurology 2017. link 3 Rollón N, Fernández-Jiménez MC, Moreno-Carralero MI, Murga-Fernández MJ, Morán-Jiménez MJ. Microcytic anemia in a pregnant woman: beyond iron deficiency. International journal of hematology 2015. link 4 Carrozzo R, Torraco A, Fiermonte G, Martinelli D, Di Nottia M, Rizza T et al.. Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2. Mitochondrion 2014. link 5 Wiseman DH, May A, Jolles S, Connor P, Powell C, Heeney MM et al.. A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood 2013. link 6 Zoraster RM, Rison RA. Severe lactic acidosis secondary to minocycline in a teenager with infectious mononucleosis and mitochondrial myopathy. Clinical neurology and neurosurgery 2008. link 7 Camaschella C. Recent advances in the understanding of inherited sideroblastic anaemia. British journal of haematology 2008. link 8 Testa M, Navazio FM, Neugebauer J. Recognition, diagnosis, and treatment of mitochondrial myopathies in endurance athletes. Current sports medicine reports 2005. link 9 Karkos PD, Waldron M, Johnson IJ. The MELAS syndrome. Review of the literature: the role of the otologist. Clinical otolaryngology and allied sciences 2004. link 10 Kumar A, Jazieh AR. Case report of sideroblastic anemia caused by ingestion of coins. American journal of hematology 2001. link66:2<126::AID-AJH1029>3.0.CO;2-J) 11 Kleinle S, Wiesmann U, Superti-Furga A, Krähenbühl S, Boltshauser E, Reichen J et al.. Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR. Human genetics 1997. link 12 Mariotti C, Uziel G, Carrara F, Mora M, Prelle A, Tiranti V et al.. Early-onset encephalomyopathy associated with tissue-specific mitochondrial DNA depletion: a morphological, biochemical and molecular-genetic study. Journal of neurology 1995. link 13 Poulton J, Sewry C, Potter CG, Bougeron T, Chretien D, Wijburg FA et al.. Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome. Journal of inherited metabolic disease 1995. link 14 Hartley C, Ascott F. Laryngeal involvement in mitochondrial myopathy. The Journal of laryngology and otology 1994. link 15 Bakker HD, Scholte HR, Jeneson JA, Busch HF, Abeling NG, van Gennip AH. Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis. Journal of inherited metabolic disease 1994. link 16 van Ekeren GJ, Stadhouders AM, Smeitink JA, Sengers RC. A retrospective study of patients with the hereditary syndrome of congenital cataract, mitochondrial myopathy of heart and skeletal muscle and lactic acidosis. European journal of pediatrics 1993. link 17 Dolan G, Reid MM. Congenital sideroblastic anaemia in two girls. Journal of clinical pathology 1991. link 18 Berkowitz K, Monteagudo A, Marks F, Jackson U, Baxi L. Mitochondrial myopathy and preeclampsia associated with pregnancy. American journal of obstetrics and gynecology 1990. link90837-w) 19 Rekhi GS. Kearns-Sayre syndrome--a case report. Indian journal of ophthalmology 1990. link 20 Doll DC, Ringenberg QS, Yarbro JW. Danazol therapy in acquired idiopathic sideroblastic anemia. Acta haematologica 1987. link 21 van Ekeren GJ, Stadhouders AM, Egberink GJ, Sengers RC, Daniëls O, Kubat K. Hereditary mitochondrial hypertrophic cardiomyopathy with mitochondrial myopathy of skeletal muscle, congenital cataract and lactic acidosis. Virchows Archiv. A, Pathological anatomy and histopathology 1987. link 22 Tanaka M, Nishikimi M, Suzuki H, Ozawa T, Okino E, Takahashi H. Multiple cytochrome deficiency and deteriorated mitochondrial polypeptide composition in fatal infantile mitochondrial myopathy and renal dysfunction. Biochemical and biophysical research communications 1986. link91166-6) 23 Schulman P, Kardon N, Weiner R, Vinciguerra V, Budman DR, Weiselberg L et al.. Acquired idiopathic sideroblastic anemia: a new chromosomal abnormality. Cancer genetics and cytogenetics 1983. link90082-1) 24 Kokkini G, Tsianos E, Kappas A. Sideroblastic anaemia associated with lincomycin therapy. Postgraduate medical journal 1983. link 25 Leveille AS, Newell FW. Autosomal dominant Kearns-Sayre syndrome. Ophthalmology 1980. link35262-7) 26 Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT et al.. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. The Journal of pediatrics 1979. link80286-3) 27 Bagnall WE, Fairman MJ. Sideroblastic and megaloblastic change. Postgraduate medical journal 1976. link

Sideroblastic anemia